PREMPRO

This brand name is authorized in United States.

Active ingredients

The drug PREMPRO contains a combination of these active pharmaceutical ingredients (APIs):

1	Estrogens, conjugated UNII IU5QR144QX - ESTROGENS, CONJUGATED
	The active ingredients of conjugated estrogens are primarily the sulfate esters of estrone, equilin sulfates, 17α-estradiol and 17β-estradiol. These substitute for the loss of estrogen production in menopausal women, and alleviate menopausal symptoms. Estrogens prevent bone loss following menopause or ovariectomy.
	Read more about Estrogens, conjugated
2	Medroxyprogesterone UNII C2QI4IOI2G - MEDROXYPROGESTERONE ACETATE
	Medroxyprogesterone acetate exerts anti-oestrogenic, anti-androgenic and antigonadotrophic effects.
	Read more about Medroxyprogesterone

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
PREMPRO Sugar-coated tablet	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
G03FB06		G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03F Progestogens and estrogens in combination → G03FB Progestogens and estrogens, sequential preparations
Discover more medicines within G03FB06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
US	FDA, National Drug Code	0046-1105, 0046-1106, 0046-1107, 0046-1108